SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001544227-20-000042
Filing Date
2020-09-24
Accepted
2020-09-24 08:33:27
Documents
15
Period of Report
2020-09-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mlnd-20200924.htm   iXBRL 8-K 48511
2 EX-99.1 exhibit991pressrelease.htm EX-99.1 16961
8 image011.jpg GRAPHIC 17769
9 image111.jpg GRAPHIC 1138
  Complete submission text file 0001544227-20-000042.txt   242302

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mlnd-20200924.xsd EX-101.SCH 2423
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mlnd-20200924_cal.xml EX-101.CAL 710
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mlnd-20200924_def.xml EX-101.DEF 1643
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mlnd-20200924_lab.xml EX-101.LAB 24993
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mlnd-20200924_pre.xml EX-101.PRE 13190
10 EXTRACTED XBRL INSTANCE DOCUMENT mlnd-20200924_htm.xml XML 12625
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35890 | Film No.: 201193585
SIC: 2834 Pharmaceutical Preparations